 Christina Coughlan
Concepts (358)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 10 | 2025 | 606 | 2.200 |
Why?
| | Extracellular Vesicles | 9 | 2025 | 162 | 2.100 |
Why?
| | Exosomes | 3 | 2023 | 108 | 0.810 |
Why?
| | Astrocytes | 4 | 2022 | 219 | 0.790 |
Why?
| | White Matter | 2 | 2023 | 146 | 0.760 |
Why?
| | Gliosis | 2 | 2023 | 29 | 0.730 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2022 | 160 | 0.720 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2025 | 112 | 0.710 |
Why?
| | Sialyltransferases | 8 | 1999 | 13 | 0.710 |
Why?
| | Amyloid beta-Protein Precursor | 5 | 2022 | 67 | 0.670 |
Why?
| | Healthy Aging | 1 | 2021 | 37 | 0.660 |
Why?
| | Ultracentrifugation | 1 | 2020 | 51 | 0.660 |
Why?
| | Memory, Episodic | 1 | 2021 | 53 | 0.650 |
Why?
| | Neurons | 8 | 2026 | 1636 | 0.570 |
Why?
| | Saccharomyces cerevisiae | 5 | 2022 | 556 | 0.550 |
Why?
| | Proteomics | 4 | 2026 | 1161 | 0.510 |
Why?
| | Amyloid beta-Peptides | 5 | 2022 | 235 | 0.500 |
Why?
| | Peptide Fragments | 3 | 2022 | 698 | 0.470 |
Why?
| | Cognitive Dysfunction | 3 | 2025 | 441 | 0.420 |
Why?
| | Nanoparticles | 1 | 2020 | 504 | 0.420 |
Why?
| | Dexamethasone | 7 | 1999 | 378 | 0.390 |
Why?
| | Brain Ischemia | 2 | 2025 | 351 | 0.330 |
Why?
| | Islet Amyloid Polypeptide | 2 | 2021 | 48 | 0.320 |
Why?
| | Herpes Zoster | 3 | 2024 | 319 | 0.320 |
Why?
| | Down Syndrome | 4 | 2022 | 514 | 0.320 |
Why?
| | Sialoglycoproteins | 3 | 1997 | 160 | 0.280 |
Why?
| | Protein Folding | 3 | 2005 | 277 | 0.270 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2025 | 153 | 0.270 |
Why?
| | Oligoclonal Bands | 1 | 2026 | 25 | 0.240 |
Why?
| | Neuroblastoma | 3 | 1999 | 165 | 0.240 |
Why?
| | Herpesvirus 3, Human | 3 | 2024 | 336 | 0.240 |
Why?
| | Proteome | 2 | 2024 | 494 | 0.230 |
Why?
| | Stroke | 3 | 2023 | 1213 | 0.230 |
Why?
| | Plasma | 2 | 2024 | 222 | 0.230 |
Why?
| | Sodium Bicarbonate | 1 | 2025 | 46 | 0.230 |
Why?
| | Biomarkers | 8 | 2025 | 4241 | 0.220 |
Why?
| | Tetraspanin 28 | 1 | 2024 | 6 | 0.220 |
Why?
| | Protein Conformation | 2 | 2005 | 942 | 0.220 |
Why?
| | Intra-Abdominal Fat | 1 | 2025 | 98 | 0.220 |
Why?
| | Chordoma | 1 | 2024 | 17 | 0.220 |
Why?
| | DNA Transposable Elements | 1 | 2025 | 121 | 0.220 |
Why?
| | Humans | 39 | 2026 | 143560 | 0.220 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2024 | 674 | 0.210 |
Why?
| | alpha-Synuclein | 1 | 2024 | 44 | 0.210 |
Why?
| | Acidosis | 1 | 2025 | 105 | 0.210 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2025 | 177 | 0.210 |
Why?
| | Amyloidogenic Proteins | 1 | 2024 | 16 | 0.210 |
Why?
| | Aprotinin | 1 | 2004 | 9 | 0.210 |
Why?
| | Varicella Zoster Virus Infection | 2 | 2024 | 24 | 0.210 |
Why?
| | Mitochondria | 2 | 2025 | 988 | 0.210 |
Why?
| | Aged, 80 and over | 8 | 2025 | 8072 | 0.210 |
Why?
| | Vacuoles | 1 | 2004 | 39 | 0.210 |
Why?
| | Osteoblasts | 1 | 2024 | 143 | 0.210 |
Why?
| | Glucocorticoids | 3 | 1999 | 537 | 0.210 |
Why?
| | Central Nervous System | 1 | 2026 | 269 | 0.210 |
Why?
| | Interleukin-6 | 2 | 2025 | 781 | 0.210 |
Why?
| | Recombinant Proteins | 2 | 2007 | 1369 | 0.200 |
Why?
| | Carcinogenesis | 1 | 2025 | 232 | 0.200 |
Why?
| | Animals | 24 | 2025 | 38010 | 0.200 |
Why?
| | Tumor Microenvironment | 2 | 2024 | 732 | 0.200 |
Why?
| | Neurodegenerative Diseases | 1 | 2005 | 143 | 0.200 |
Why?
| | Bleomycin | 1 | 2024 | 242 | 0.190 |
Why?
| | Cerebrovascular Circulation | 1 | 2025 | 272 | 0.190 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 219 | 0.190 |
Why?
| | Diabetic Neuropathies | 1 | 2023 | 97 | 0.190 |
Why?
| | Colon | 1 | 2025 | 306 | 0.190 |
Why?
| | Apolipoprotein E4 | 1 | 2022 | 38 | 0.180 |
Why?
| | Ischemic Attack, Transient | 1 | 2023 | 71 | 0.180 |
Why?
| | Disease | 1 | 2003 | 99 | 0.180 |
Why?
| | Protein Processing, Post-Translational | 4 | 2011 | 474 | 0.180 |
Why?
| | Obesity | 2 | 2025 | 3041 | 0.180 |
Why?
| | Fatty Acids | 1 | 2025 | 452 | 0.180 |
Why?
| | Cognition | 3 | 2025 | 1261 | 0.180 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2025 | 308 | 0.180 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2024 | 639 | 0.180 |
Why?
| | Immunoglobulin G | 1 | 2026 | 898 | 0.180 |
Why?
| | Endoplasmic Reticulum | 1 | 2004 | 263 | 0.180 |
Why?
| | Retinal Drusen | 1 | 2021 | 31 | 0.170 |
Why?
| | Peptides | 2 | 2024 | 976 | 0.170 |
Why?
| | Virion | 1 | 2022 | 114 | 0.170 |
Why?
| | Retinal Pigment Epithelium | 1 | 2021 | 81 | 0.170 |
Why?
| | Aldosterone | 4 | 1999 | 43 | 0.170 |
Why?
| | Arteritis | 1 | 2021 | 25 | 0.170 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2022 | 79 | 0.170 |
Why?
| | Chemical Precipitation | 1 | 2020 | 39 | 0.170 |
Why?
| | Cell Polarity | 1 | 2021 | 140 | 0.160 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2021 | 142 | 0.160 |
Why?
| | Myelitis | 1 | 2022 | 106 | 0.160 |
Why?
| | Stem Cells | 1 | 2025 | 619 | 0.160 |
Why?
| | Aged | 12 | 2025 | 25322 | 0.160 |
Why?
| | Adipose Tissue | 1 | 2025 | 654 | 0.160 |
Why?
| | Enterovirus D, Human | 1 | 2022 | 87 | 0.160 |
Why?
| | Epigenesis, Genetic | 1 | 2025 | 686 | 0.160 |
Why?
| | Amyloid | 1 | 2021 | 96 | 0.160 |
Why?
| | Multiple Sclerosis | 1 | 2026 | 483 | 0.160 |
Why?
| | Receptors, Chemokine | 1 | 2000 | 48 | 0.160 |
Why?
| | Cell Movement | 1 | 2024 | 973 | 0.160 |
Why?
| | Neuromuscular Diseases | 1 | 2022 | 146 | 0.160 |
Why?
| | Chemokine CCL2 | 1 | 2000 | 115 | 0.150 |
Why?
| | Macular Degeneration | 1 | 2021 | 189 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 3 | 1999 | 505 | 0.150 |
Why?
| | Enterovirus Infections | 1 | 2022 | 174 | 0.150 |
Why?
| | Wnt-5a Protein | 1 | 2018 | 25 | 0.150 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 637 | 0.150 |
Why?
| | Fibroblasts | 1 | 2024 | 1044 | 0.140 |
Why?
| | Signal Transduction | 4 | 2021 | 5214 | 0.140 |
Why?
| | Apoptosis | 4 | 2026 | 2519 | 0.140 |
Why?
| | Cell Line, Tumor | 5 | 2025 | 3611 | 0.140 |
Why?
| | Aging | 3 | 2025 | 1946 | 0.140 |
Why?
| | Frontotemporal Lobar Degeneration | 1 | 2017 | 19 | 0.140 |
Why?
| | Cell Communication | 2 | 2000 | 313 | 0.130 |
Why?
| | Middle Aged | 11 | 2026 | 35342 | 0.130 |
Why?
| | N-Acetylneuraminic Acid | 2 | 1999 | 14 | 0.130 |
Why?
| | Kidney | 2 | 2015 | 1507 | 0.130 |
Why?
| | Colorectal Neoplasms | 1 | 2025 | 833 | 0.130 |
Why?
| | Proteostasis Deficiencies | 1 | 2017 | 5 | 0.130 |
Why?
| | Aneuploidy | 1 | 2017 | 89 | 0.130 |
Why?
| | Melanoma | 1 | 2024 | 807 | 0.130 |
Why?
| | Pancreatic Neoplasms | 1 | 2025 | 924 | 0.130 |
Why?
| | Male | 16 | 2026 | 71500 | 0.130 |
Why?
| | tau Proteins | 1 | 2017 | 98 | 0.130 |
Why?
| | Tumor Cells, Cultured | 5 | 2000 | 974 | 0.130 |
Why?
| | Glycosylation | 4 | 2026 | 173 | 0.120 |
Why?
| | Trisomy | 1 | 2017 | 78 | 0.120 |
Why?
| | Brain Chemistry | 1 | 1996 | 115 | 0.120 |
Why?
| | Female | 15 | 2026 | 77251 | 0.120 |
Why?
| | Proteins | 1 | 2021 | 1022 | 0.120 |
Why?
| | Isoenzymes | 1 | 1996 | 299 | 0.110 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2025 | 43 | 0.110 |
Why?
| | Carcinoma, Hepatocellular | 2 | 1997 | 365 | 0.110 |
Why?
| | Rats | 8 | 2025 | 5610 | 0.110 |
Why?
| | Cystic Fibrosis | 1 | 2005 | 1142 | 0.110 |
Why?
| | Models, Biological | 1 | 2003 | 1831 | 0.110 |
Why?
| | Neurofilament Proteins | 2 | 2025 | 62 | 0.110 |
Why?
| | Molecular Sequence Data | 5 | 2015 | 2942 | 0.100 |
Why?
| | Brain | 4 | 2023 | 2892 | 0.100 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4522 | 0.100 |
Why?
| | Mice | 10 | 2025 | 18378 | 0.100 |
Why?
| | Oxidative Stress | 2 | 2021 | 1370 | 0.100 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 262 | 0.100 |
Why?
| | Membrane Proteins | 3 | 2024 | 1171 | 0.090 |
Why?
| | Enzyme Induction | 3 | 1997 | 89 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 1996 | 607 | 0.090 |
Why?
| | Amino Acid Sequence | 3 | 2015 | 2165 | 0.090 |
Why?
| | Transcription Factor AP-2 | 1 | 2011 | 82 | 0.090 |
Why?
| | Glioma | 1 | 1995 | 425 | 0.080 |
Why?
| | Parkinson Disease | 1 | 2017 | 576 | 0.080 |
Why?
| | Adult | 6 | 2026 | 40013 | 0.080 |
Why?
| | Ethanol | 1 | 2015 | 639 | 0.080 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 6043 | 0.080 |
Why?
| | Adrenalectomy | 4 | 1999 | 70 | 0.080 |
Why?
| | Membrane Transport Proteins | 1 | 2011 | 156 | 0.080 |
Why?
| | Cells, Cultured | 4 | 2021 | 4182 | 0.080 |
Why?
| | Palliative Care | 1 | 2017 | 852 | 0.080 |
Why?
| | Receptors, Nicotinic | 1 | 2011 | 344 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2575 | 0.070 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 1207 | 0.070 |
Why?
| | Caregivers | 1 | 2017 | 970 | 0.070 |
Why?
| | Alcoholism | 1 | 2015 | 838 | 0.070 |
Why?
| | DNA-Binding Proteins | 2 | 2025 | 1524 | 0.070 |
Why?
| | Schizophrenia | 1 | 2011 | 442 | 0.070 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2011 | 403 | 0.070 |
Why?
| | Liver | 1 | 1996 | 1864 | 0.060 |
Why?
| | Drug Stability | 1 | 2007 | 165 | 0.060 |
Why?
| | Transcription Factors | 2 | 2025 | 1754 | 0.060 |
Why?
| | DNA Primers | 1 | 2007 | 518 | 0.060 |
Why?
| | Golgi Apparatus | 2 | 2004 | 100 | 0.060 |
Why?
| | Polysaccharides | 2 | 2004 | 88 | 0.060 |
Why?
| | Mutation | 4 | 2017 | 4053 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 61 | 0.060 |
Why?
| | Middle Cerebral Artery | 1 | 2025 | 55 | 0.060 |
Why?
| | Protein Aggregates | 1 | 2026 | 83 | 0.060 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2025 | 45 | 0.060 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2024 | 389 | 0.060 |
Why?
| | Cytokines | 2 | 2024 | 2097 | 0.060 |
Why?
| | DNA Methylation | 2 | 2025 | 667 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2023 | 3625 | 0.050 |
Why?
| | Calnexin | 1 | 2004 | 3 | 0.050 |
Why?
| | Centrifugation, Density Gradient | 1 | 2004 | 39 | 0.050 |
Why?
| | Cycloheximide | 1 | 2004 | 49 | 0.050 |
Why?
| | Concanavalin A | 1 | 2004 | 72 | 0.050 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2004 | 47 | 0.050 |
Why?
| | Kinetics | 2 | 1998 | 1628 | 0.050 |
Why?
| | Precipitin Tests | 1 | 2004 | 97 | 0.050 |
Why?
| | Mass Spectrometry | 1 | 2007 | 740 | 0.050 |
Why?
| | Cell Death | 1 | 2025 | 394 | 0.050 |
Why?
| | Virus Activation | 1 | 2024 | 86 | 0.050 |
Why?
| | Fluorescent Dyes | 1 | 2025 | 325 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2004 | 66 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2004 | 74 | 0.050 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2004 | 46 | 0.050 |
Why?
| | Base Sequence | 1 | 2007 | 2199 | 0.050 |
Why?
| | Intermediate Filaments | 1 | 2023 | 26 | 0.050 |
Why?
| | Glycolysis | 1 | 2025 | 335 | 0.050 |
Why?
| | Disulfides | 1 | 2004 | 99 | 0.050 |
Why?
| | Time Factors | 2 | 2025 | 7031 | 0.050 |
Why?
| | Hippocampus | 2 | 2022 | 948 | 0.050 |
Why?
| | Sucrose | 1 | 2004 | 111 | 0.050 |
Why?
| | Diet, High-Fat | 1 | 2025 | 260 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 101 | 0.050 |
Why?
| | Fungal Proteins | 1 | 2004 | 141 | 0.050 |
Why?
| | Chemokines, CXC | 1 | 2003 | 70 | 0.050 |
Why?
| | Carbohydrate Sequence | 3 | 1999 | 29 | 0.050 |
Why?
| | Neurites | 1 | 2023 | 52 | 0.050 |
Why?
| | Diffusion Tensor Imaging | 1 | 2023 | 75 | 0.050 |
Why?
| | beta Catenin | 1 | 2025 | 256 | 0.050 |
Why?
| | Plasmids | 1 | 2004 | 371 | 0.050 |
Why?
| | Imipramine | 1 | 2022 | 11 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 87 | 0.050 |
Why?
| | Inflammation | 2 | 2025 | 2881 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 213 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 69 | 0.050 |
Why?
| | Chemokines | 1 | 2003 | 223 | 0.050 |
Why?
| | Densitometry | 1 | 2022 | 38 | 0.050 |
Why?
| | Retinal Ganglion Cells | 1 | 2003 | 120 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2621 | 0.050 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2023 | 156 | 0.050 |
Why?
| | Virus Internalization | 1 | 2022 | 64 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2024 | 484 | 0.040 |
Why?
| | Polymerization | 1 | 2022 | 128 | 0.040 |
Why?
| | Viral Proteins | 1 | 2024 | 370 | 0.040 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 863 | 0.040 |
Why?
| | Catalysis | 1 | 2022 | 322 | 0.040 |
Why?
| | Cattle | 1 | 2004 | 990 | 0.040 |
Why?
| | Chromatin | 1 | 2025 | 554 | 0.040 |
Why?
| | Lectins | 2 | 1998 | 43 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2025 | 1091 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2025 | 3109 | 0.040 |
Why?
| | Interneurons | 1 | 2022 | 124 | 0.040 |
Why?
| | Receptors, HIV | 1 | 2000 | 25 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2023 | 239 | 0.040 |
Why?
| | Neuroimaging | 1 | 2023 | 282 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2021 | 277 | 0.040 |
Why?
| | Immune System | 1 | 2022 | 183 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 318 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 1984 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2017 | 0.040 |
Why?
| | Retina | 1 | 2003 | 324 | 0.040 |
Why?
| | Teratocarcinoma | 1 | 2000 | 2 | 0.040 |
Why?
| | Organoids | 1 | 2021 | 133 | 0.040 |
Why?
| | Phagocytosis | 1 | 2021 | 291 | 0.040 |
Why?
| | Receptors, Dopamine D2 | 1 | 2000 | 96 | 0.040 |
Why?
| | Intracellular Space | 1 | 2020 | 67 | 0.040 |
Why?
| | Acyclovir | 1 | 2020 | 96 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1838 | 0.040 |
Why?
| | Extracellular Space | 1 | 2020 | 129 | 0.040 |
Why?
| | Phytohemagglutinins | 1 | 1999 | 29 | 0.040 |
Why?
| | Viral Envelope Proteins | 1 | 2020 | 98 | 0.040 |
Why?
| | Cerebral Palsy | 1 | 2021 | 129 | 0.040 |
Why?
| | Cell Line | 2 | 2022 | 2897 | 0.040 |
Why?
| | DNA, Viral | 1 | 2021 | 366 | 0.040 |
Why?
| | Thrombosis | 1 | 2023 | 401 | 0.040 |
Why?
| | Nicotine | 1 | 2021 | 342 | 0.040 |
Why?
| | Genotype | 1 | 2004 | 1877 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2000 | 219 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 642 | 0.040 |
Why?
| | Biomarkers, Tumor | 1 | 2025 | 1282 | 0.040 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 272 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2011 | 2852 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2024 | 1487 | 0.030 |
Why?
| | Fetuins | 1 | 1997 | 2 | 0.030 |
Why?
| | Asialoglycoproteins | 1 | 1997 | 2 | 0.030 |
Why?
| | Cytidine Monophosphate N-Acetylneuraminic Acid | 1 | 1997 | 3 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2000 | 248 | 0.030 |
Why?
| | MicroRNAs | 1 | 2024 | 698 | 0.030 |
Why?
| | Nervous System | 1 | 1998 | 70 | 0.030 |
Why?
| | Protein Binding | 1 | 2004 | 2261 | 0.030 |
Why?
| | alpha-Fetoproteins | 1 | 1997 | 40 | 0.030 |
Why?
| | Homozygote | 1 | 2017 | 201 | 0.030 |
Why?
| | Gene Dosage | 1 | 2017 | 149 | 0.030 |
Why?
| | Tretinoin | 1 | 1998 | 124 | 0.030 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2017 | 42 | 0.030 |
Why?
| | Heterozygote | 1 | 2017 | 311 | 0.030 |
Why?
| | Carbohydrate Conformation | 1 | 1996 | 15 | 0.030 |
Why?
| | Glycoproteins | 1 | 1998 | 356 | 0.030 |
Why?
| | Oligosaccharides | 1 | 1996 | 60 | 0.030 |
Why?
| | Parietal Lobe | 1 | 1996 | 59 | 0.030 |
Why?
| | Glutathione Reductase | 1 | 2015 | 25 | 0.030 |
Why?
| | Peroxiredoxins | 1 | 2015 | 26 | 0.030 |
Why?
| | Substrate Specificity | 1 | 1996 | 383 | 0.030 |
Why?
| | Brain Stem | 1 | 1996 | 96 | 0.030 |
Why?
| | Glutathione Transferase | 1 | 2015 | 99 | 0.030 |
Why?
| | Fetus | 1 | 2000 | 806 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 1998 | 280 | 0.030 |
Why?
| | Adolescent | 2 | 2025 | 22481 | 0.030 |
Why?
| | Acetylation | 1 | 2015 | 249 | 0.030 |
Why?
| | Aldehydes | 1 | 2015 | 146 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2015 | 209 | 0.030 |
Why?
| | Focus Groups | 1 | 2017 | 570 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2017 | 535 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2020 | 764 | 0.030 |
Why?
| | Cerebellum | 1 | 1996 | 222 | 0.030 |
Why?
| | Risk Assessment | 1 | 2023 | 3577 | 0.020 |
Why?
| | Glutathione | 1 | 2015 | 373 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2017 | 868 | 0.020 |
Why?
| | Cell Differentiation | 2 | 1998 | 2020 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2015 | 346 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2017 | 2194 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 1995 | 443 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 524 | 0.020 |
Why?
| | SEC Translocation Channels | 1 | 2011 | 10 | 0.020 |
Why?
| | Amino Acids | 1 | 2015 | 511 | 0.020 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2011 | 97 | 0.020 |
Why?
| | Lung | 1 | 2024 | 4101 | 0.020 |
Why?
| | Protein Stability | 1 | 2011 | 175 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2011 | 382 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 190 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11737 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2011 | 342 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5743 | 0.020 |
Why?
| | HeLa Cells | 1 | 2011 | 650 | 0.020 |
Why?
| | Protein Transport | 1 | 2011 | 447 | 0.020 |
Why?
| | Qualitative Research | 1 | 2017 | 1563 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 637 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 13972 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2023 | 11365 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1263 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 1998 | 2195 | 0.020 |
Why?
| | Child | 1 | 2025 | 22725 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2011 | 1511 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 16741 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2003 | 129 | 0.010 |
Why?
| | Chick Embryo | 1 | 2003 | 136 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2003 | 74 | 0.010 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2003 | 82 | 0.010 |
Why?
| | Chemokine CXCL12 | 1 | 2003 | 89 | 0.010 |
Why?
| | Nerve Growth Factors | 1 | 2003 | 79 | 0.010 |
Why?
| | Receptors, CXCR4 | 1 | 2003 | 91 | 0.010 |
Why?
| | Infant | 1 | 2017 | 9981 | 0.010 |
Why?
| | Cell Count | 1 | 2003 | 323 | 0.010 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 128 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2003 | 215 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 302 | 0.010 |
Why?
| | Dopamine D2 Receptor Antagonists | 1 | 2000 | 4 | 0.010 |
Why?
| | Apelin Receptors | 1 | 2000 | 4 | 0.010 |
Why?
| | Apelin | 1 | 2000 | 10 | 0.010 |
Why?
| | Adipokines | 1 | 2000 | 53 | 0.010 |
Why?
| | Receptors, Virus | 1 | 2000 | 95 | 0.010 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2000 | 92 | 0.010 |
Why?
| | Cell Survival | 1 | 2003 | 1136 | 0.010 |
Why?
| | Primates | 1 | 2000 | 133 | 0.010 |
Why?
| | Swainsonine | 1 | 1999 | 1 | 0.010 |
Why?
| | 1-Deoxynojirimycin | 1 | 1999 | 1 | 0.010 |
Why?
| | Mannosidases | 1 | 1999 | 4 | 0.010 |
Why?
| | Neuraminidase | 1 | 1999 | 25 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 330 | 0.010 |
Why?
| | Phosphorylation | 1 | 2003 | 1781 | 0.010 |
Why?
| | Transfection | 1 | 2000 | 949 | 0.010 |
Why?
| | Biological Transport | 1 | 1999 | 412 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2000 | 1272 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2000 | 589 | 0.010 |
Why?
| | Solubility | 1 | 1998 | 239 | 0.010 |
Why?
| | Blotting, Western | 1 | 1999 | 1223 | 0.010 |
Why?
| | Pituitary Neoplasms | 1 | 1999 | 195 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 752 | 0.010 |
Why?
| | HIV-1 | 1 | 2000 | 892 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2000 | 1474 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2000 | 2026 | 0.010 |
Why?
|
|
Coughlan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|